Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2021-06-15
2024-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache
NCT00407992
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine
NCT04604977
Gene Expression of Endocannabinoid System in Episodic and Chronic Migraine Patients
NCT04324710
Efficacy of OnabotulinumtoxinA in Migraine
NCT04578782
Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects
NCT04473976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects and methods. The investigators will enroll 30 subjects with EM, 30 patients with CM (with and without MOH), and 30 healthy control subjects. Patients with EM during the preictal, ictal, and postictal phases will be also enrolled. All participants underwent an experimental paradigm consisting of three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT). All tests will be carried out by using a Q-sense CPM device (Medoc) and computerized visual analogue scale (CoVAS).
Experimental paradigms. All subjects will be assessed in a single experimental session. After obtaining written consent, participants will complete various questionnaires. The Heat Pain Threshold (HPT) will be then measured on the forehead (1st branch of the trigeminal nerve, V1), followed by three constant trials (CT) and three offset-analgesia trials (OT) in the same area. The following questionnaires will be administered: 12-item Allodynia Symptom Checklist (ASC-12), Migraine Disability Assessment (MIDAS), and Hospital Anxiety and Depression Scale (HADS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group with episodic migraine (EM)
Subjects with episodic migraine (EM) with or without aura according to the International Headache Society (IHS) Classification (3rd edition).
Chronic Migraine (CM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Group with chronic migraine (EC)
Subjects with chronic migraine (CM) with or without Medication Overuse (MO) according to the International Headache Society (IHS) Classification (3rd edition).
Episodic Migraine (EM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Control group
Age- and sex-matched controls.
Episodic Migraine (EM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Chronic Migraine (CM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Episodic Migraine (EM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Chronic Migraine (CM)
Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* other acute or chronic pain conditions
* serious internal, psychiatric, or neurological systemic diseases
* pregnancy, breastfeeding, skin pathologies in the tested trigeminal nerve area (V1)
* poor sleep quality the night before testing
* alcohol consumption or intense exercise within 24 hours prior to examination
* women were not assessed during their menstrual cycle.
* Use of migraine prophylactic medication for patients with EM.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS National Neurological Institute "C. Mondino" Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Cosentino, MD
Role: PRINCIPAL_INVESTIGATOR
Translational Neurophysiology - Headache and Neurorehabilitation Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Trial Center
Pavia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cosentino G, Fierro B, Vigneri S, Talamanca S, Paladino P, Baschi R, Indovino S, Maccora S, Valentino F, Fileccia E, Giglia G, Brighina F. Cyclical changes of cortical excitability and metaplasticity in migraine: evidence from a repetitive transcranial magnetic stimulation study. Pain. 2014 Jun;155(6):1070-1078. doi: 10.1016/j.pain.2014.02.024. Epub 2014 Mar 13.
Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016 Jul;139(Pt 7):1987-93. doi: 10.1093/brain/aww097. Epub 2016 May 5.
Tassorelli C, Greco R, Silberstein SD. The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol. 2019 Jun;32(3):405-412. doi: 10.1097/WCO.0000000000000688.
Szikszay TM, Adamczyk WM, Carvalho GF, May A, Luedtke K. Offset analgesia: somatotopic endogenous pain modulation in migraine. Pain. 2020 Mar;161(3):557-564. doi: 10.1097/j.pain.0000000000001739.
de Tommaso M, Losito L, Difruscolo O, Sardaro M, Libro G, Guido M, Lamberti P, Livrea P. Capsaicin failed in suppressing cortical processing of CO2 laser pain in migraine patients. Neurosci Lett. 2005 Aug 12-19;384(1-2):150-5. doi: 10.1016/j.neulet.2005.04.086.
de Tommaso M, Difruscolo O, Sardaro M, Libro G, Pecoraro C, Serpino C, Lamberti P, Livrea P. Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients. J Headache Pain. 2007 Jun;8(3):167-74. doi: 10.1007/s10194-007-0385-8. Epub 2007 Jun 11.
Coppola G, Di Clemente L, Fumal A, Magis D, De Pasqua V, Pierelli F, Schoenen J. Inhibition of the nociceptive R2 blink reflex after supraorbital or index finger stimulation is normal in migraine without aura between attacks. Cephalalgia. 2007 Jul;27(7):803-8. doi: 10.1111/j.1468-2982.2007.01323.x.
Perrotta A, Serrao M, Sandrini G, Burstein R, Sances G, Rossi P, Bartolo M, Pierelli F, Nappi G. Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia. 2010 Mar;30(3):272-84. doi: 10.1111/j.1468-2982.2009.01914.x. Epub 2010 Feb 15.
Grill JD, Coghill RC. Transient analgesia evoked by noxious stimulus offset. J Neurophysiol. 2002 Apr;87(4):2205-8. doi: 10.1152/jn.00730.2001.
Ligato D, Petersen KK, Morch CD, Arendt-Nielsen L. Offset analgesia: The role of peripheral and central mechanisms. Eur J Pain. 2018 Jan;22(1):142-149. doi: 10.1002/ejp.1110. Epub 2017 Sep 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MigOA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.